| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Sep 16, 2024 | Lappe Mark CEO | Buy | Inhibrx Biosciences, Inc. | INBX | $15.73 | $629,117 | +4.14% |
| Sep 06, 2024 | Sep 10, 2024 | Lappe Mark CEO | Buy | Inhibrx Biosciences, Inc. | INBX | $15.25 | $671,150 | +4.73% |
| Aug 29, 2024 | Sep 03, 2024 | Lappe Mark CEO | Buy | Inhibrx Biosciences, Inc. | INBX | $14.92 | $596,763 | +4.54% |
| Aug 20, 2024 | Aug 22, 2024 | Lappe Mark CEO | Buy | Inhibrx Biosciences, Inc. | INBX | $12.96 | $518,282 | +4.75% |
| Feb 28, 2023 | Mar 01, 2023 | Lappe Mark CEO | Sell | Inhibrx, Inc. | INBX | $25.02 | $1,501 | -0.00% |
| Jan 23, 2023 | Jan 24, 2023 | Lappe Mark CEO | Sell | Inhibrx, Inc. | INBX | $25.42 | $660,842 | -0.85% |
| Dec 19, 2022 | Dec 20, 2022 | Lappe Mark CEO | Sell | Inhibrx, Inc. | INBX | $25.56 | $664,443 | -0.84% |
| Nov 17, 2022 | Nov 18, 2022 | Lappe Mark CEO | Sell | Inhibrx, Inc. | INBX | $27.88 | $724,910 | -0.83% |
| Oct 17, 2022 | Oct 18, 2022 | Lappe Mark CEO | Sell | Inhibrx, Inc. | INBX | $29.59 | $769,443 | -0.83% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.